Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Item
http://www.wikidata.org/entity/Q35410420
Pseudomonas aeruginosa ventilator-associated pneumonia managementVaccines for Pseudomonas aeruginosa: a long and winding roadMucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strainsSafety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infectionThe C-terminal domain of Salmonella enterica serovar typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surfaceContribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infectionMolecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira speciesRecent developments for Pseudomonas vaccines.Use of the pre-pro part of Staphylococcus hyicus lipase as a carrier for secretion of Escherichia coli outer membrane protein A (OmpA) prevents proteolytic degradation of OmpA by cell-associated protease(s) in two different gram-positive bacteria.Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella.A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
P2860

Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Item
http://www.wikidata.org/entity/Q35410420
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Protection of immunocompromise ...... ane protein I fusion proteins.
@ast
Protection of immunocompromise ...... ane protein I fusion proteins.
@en
type
label
Protection of immunocompromise ...... ane protein I fusion proteins.
@ast
Protection of immunocompromise ...... ane protein I fusion proteins.
@en
prefLabel
Protection of immunocompromise ...... ane protein I fusion proteins.
@ast
Protection of immunocompromise ...... ane protein I fusion proteins.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932
P1433
P1476
Protection of immunocompromise ...... ane protein I fusion proteins.
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932